Figure 1.
Change in Myasthenia Gravis Composite Score before and 6 weeks after transition to eculizumab in patients with generalized refractory myasthenia gravis. Pt – patient.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.